Use of proton pump inhibitors is associated with fractures in young adults: a population-based study

被引:79
|
作者
Freedberg, D. E. [1 ]
Haynes, K. [2 ]
Denburg, M. R. [3 ]
Zemel, B. S. [4 ]
Leonard, M. B. [5 ,6 ]
Abrams, J. A. [1 ]
Yang, Y. -X. [2 ,7 ]
机构
[1] Columbia Univ, Div Digest & Liver Dis, Med Ctr, New York, NY 10032 USA
[2] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[5] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA
[6] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA
[7] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA
关键词
Acid suppression medications; Bone mineral density; Fracture; Histamine-2 receptor antagonists; Osteoporosis; Outcomes research; Pediatrics; Pharmacoepidemiology; Proton pump inhibitors; BONE-MINERAL DENSITY; GASTROESOPHAGEAL-REFLUX DISEASE; NETWORK THIN DATABASE; CALCIUM-ABSORPTION; RISK; CHILDREN; EPIDEMIOLOGY; VALIDATION; ACID; OSTEOPOROSIS;
D O I
10.1007/s00198-015-3168-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Summary Proton pump inhibitors (PPIs) are associated with risk for fracture in osteoporotic adults. In this population-based study, we found a significant association between PPIs and fracture in young adults, with evidence of a dose-response effect. Young adults who use PPIs should be cautioned regarding risk for fracture. Introduction Proton pump inhibitors (PPIs) are associated with fracture in adults with osteoporosis. Because PPI therapy may interfere with bone accrual and attainment of peak bone mineral density, we studied the association between use of PPIs and fracture in children and young adults. Methods We conducted a population-based, case-control study nested within records from general medical practices from 1994 to 2013. Participants were 4-29 years old with a parts per thousand yen1 year of follow-up who lacked chronic conditions associated with use of long-term acid suppression. Cases of fracture were defined as the first incident fracture at any site. Using incidence density sampling, cases were matched with up to five controls by age, sex, medical practice, and start of follow-up. PPI exposure was defined as 180 or more cumulative doses of PPIs. Conditional logistic regression was used to estimate the odds ratio and confidence interval for use of PPIs and fracture. Results We identified 124,799 cases and 605,643 controls. The adjusted odds ratio for the risk of fracture associated with PPI exposure was 1.13 (95 % CI 0.92 to 1.39) among children aged < 18 years old and 1.39 (95 % CI 1.26 to 1.53) among young adults aged 18-29 years old. In young adults but not children, we observed a dose-response effect with increased total exposure to PPIs (p for trend < 0.001). Conclusions PPI use was associated with fracture in young adults, but overall evidence did not support a PPI-fracture relationship in children. Young adults who use PPIs should be cautioned regarding potentially increased risk for fracture, even if they lack traditional fracture risk factors.
引用
收藏
页码:2501 / 2507
页数:7
相关论文
共 50 条
  • [1] Use of proton pump inhibitors is associated with fractures in young adults: a population-based study
    D. E. Freedberg
    K. Haynes
    M. R. Denburg
    B. S. Zemel
    M. B. Leonard
    J. A. Abrams
    Y.-X. Yang
    Osteoporosis International, 2015, 26 : 2501 - 2507
  • [2] Use of Proton Pump Inhibitors Is Associated With Non-Osteoporotic Fractures: A Population-Based Study
    Freedberg, Daniel E.
    Haynes, Kevin
    Denburg, Michelle
    Zemel, Babette S.
    Leonard, Mary B.
    Abrams, Julian A.
    Yang, Yu-Xiao
    GASTROENTEROLOGY, 2015, 148 (04) : S619 - S620
  • [3] Use of proton-pump inhibitors is associated with depression: a population-based study
    Laudisio, Alice
    Incalzi, Raffaele Antonelli
    Gemma, Antonella
    Giovannini, Silvia
    Lo Monaco, Maria Rita
    Vetrano, Davide L.
    Padua, Luca
    Bernabei, Roberto
    Zuccala, Giuseppe
    INTERNATIONAL PSYCHOGERIATRICS, 2018, 30 (01) : 153 - 159
  • [4] Use of proton pump inhibitors and risk of rosacea: A nationwide population-based study
    Dai, Ying-Xiu
    Tai, Ying-Hsuan
    Chen, Chih-Chiang
    Chang, Yun-Ting
    Chen, Tzeng-Ji
    Chen, Mu-Hong
    JOURNAL OF DERMATOLOGY, 2020, 47 (10): : 1126 - 1130
  • [5] Proton Pump Inhibitors Use in Kidney Transplant Recipients: A Population-Based Study
    Kiberd, James
    Quinn, Robert R.
    Ravani, Pietro
    Lentine, Krista L.
    Clarke, Alix
    Jeong, Rachel
    Faruque, Labib
    Lam, Ngan N.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2024, 11
  • [6] Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based study
    Labenz, Christian
    Woerns, Marcus-Alexander
    Adarkwah, Charles C.
    Galle, Peter R.
    Schattenberg, Joern M.
    Kostev, Karel
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (06) : 1042 - 1050
  • [7] Proton pump inhibitors and dementia: A nationwide population-based study
    Lu, Jinmiao
    Wang, Yi
    Li, Zhiping
    ALZHEIMERS & DEMENTIA, 2024, 20 (03) : 2285 - 2286
  • [8] Proton pump inhibitors and dementia: A nationwide population-based study
    Pourhadi, Nelsan
    Janbek, Janet
    Jensen-Dahm, Christina
    Gasse, Christiane
    Laursen, Thomas Munk
    Waldemar, Gunhild
    ALZHEIMERS & DEMENTIA, 2024, 20 (02) : 837 - 845
  • [9] Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population-Based Cohort Study
    Kieboom, Brenda C. T.
    Kiefte-de Jong, Jessica C.
    Eijgelsheim, Mark
    Franco, Oscar H.
    Kuipers, Ernst J.
    Hofman, Albert
    Zietse, Robert
    Stricker, Bruno H.
    Hoorn, Ewout J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (05) : 775 - 782
  • [10] Use of Proton Pump Inhibitors and Risk of Major Depressive Disorder: A Nationwide Population-Based Study
    Huang, Wei-Sheng
    Bai, Ya-Mei
    Hsu, Ju-Wei
    Huang, Kai-Lin
    Tsai, Chia-Fen
    Su, Tung-Ping
    Li, Cheng-Ta
    Lin, Wei-Chen
    Tsai, Shih-Jen
    Pan, Tai-Long
    Chen, Tzeng-Ji
    Chen, Mu-Hong
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2018, 87 (01) : 62 - 64